FDA Inspection 1199006 — U.S. Infusion, LLC

U.S. Infusion, LLC — FEI 3008782867

The FDA completed an inspection of U.S. Infusion, LLC on March 6, 2023 in South Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 6, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
South Miami, FL (United States)

Citations

IDCFRDescription
369621 CFR 820.100(b)Documentation
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements